| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| D795312 | MACKLIN | 盐酸度洛西汀 | 10mM in DMSO | 362元/1ml; | 展开 |
|
| D808419 | MACKLIN | 盐酸度洛西汀 | ≥98.0%(HPLC) | 33元/200mg; 76元/1g; 192元/5g; 616元/25g; 2021元/100g; | 展开 |
|
| D4223 | TCI | Duloxetine Hydrochloride | >98.0%(T)(HPLC) | 80元/1G; 190元/5G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C18H19NOS・HCl = 333.87 | | 外观与形状(20℃) | 固体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 空气 | | 包装和容器 | 1G-带有塑料内管的玻璃瓶 (查看图片) | | 相关CAS RN | 116539-59-4 | | Reaxys-RN | 8168890 | | PubChem物质ID | 160871378 | | Merck Index (14) | 3465 | | MDL编号 | MFCD06407958 |
技术规格 | Appearance | White to Light yellow to Light orange powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Melting point | 161.0 to 165.0 ℃ | | Specific rotation [a]20/D | +120 to +124 deg(C=1, MeOH) |
物性(参考值) | 熔点 | 164 ℃ | | 比旋光度 [α]D | 122° (C=1,MeOH) | | 溶解性(可溶于) | 甲醇 |
安全信息 | 图形或危害标志 |  | | 信号词 | 警告 | | 危险性说明 | H361 : 怀疑对生育能力或胎儿造成伤害。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P202 : 在阅读并明了所有安全措施前切勿搬动。 P201 : 使用前取得专用说明。 P280 : 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P308 + P313 : 如接触到或有疑虑:求医/就诊。 P405 : 存放处须加锁。
|
相关法规 |
| 365552 | J&K | Duloxetine Hydrochloride | 99%, 是5-羟色胺-去甲肾上腺素重吸收抑制剂(SNRI),Ki为 4.6 nM | 808元/1G; 2613元/5G; | 展开 |
基本信息 | 分子式 | C18H19NOS·HCl | | 分子量 | 333.88 | | 熔点 | 161-165 | | 比旋光度([α]20D) | 115.5° to 124.5° (C=1, MeOH) | | MDL编码 | MFCD06407958 | | Beilstein | N/A
8168890 | | 存储条件 | Freezer -20℃ | 产品描述 Duloxetine HCl是一种5-羟色胺-去甲肾上腺素再摄取抑制剂,Ki为4.6 nM,用于治疗重度抑郁症和广泛性焦虑症(GAD)。 靶点(IC50 & Targe) DA transporter Noradrenaline transporter (Sodium-dependent) ert (Sodium-dependent) 参考文献 [1] Wong DT, et al. Life Sci, 1988, 43(24):2049-57. 安全信息 | 图形或危害标志 |   | | 提示语 | Warning | | 危险说明 | H302 H410 | | 防范说明 | P264 P270 P273 P301+P312 P501 | | UN号码 | 3077 | | 危险分类 | 9 | | 包装等级 | III | | RTECS | XN0258000 |
|
| C46314 | Alfa Aesar | Duloxetine Hydrochloride | | 1574元/1g; 6200元/5g; | 展开 |
基本信息 Ref# 46314 分子式 C18H19NOS.HCl 分子量 482.44 GHS危害和防范说明 GHS符号
 Hazard Statements H361 Suspected of damaging fertility or the unborn child. Precautionary Statements P201 P280 P308+P313 |
| Y0001454 | | Duloxetine for system suitability | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 盐酸度洛西汀是一种双重血清素/去甲肾上腺素再摄取抑制剂(SNRI),在临床上被广泛用作抗抑郁药和抗焦虑药。 包装 Unit quantity: 40 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C18H19NOS · HCl | | 分子量 | 333.88 | | MDL编号 | MFCD06407958 | | PubChem化学物质编号 | 329831431 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3 | | InChI | 1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1 | | InChI key | BFFSMCNJSOPUAY-LMOVPXPDSA-N | | Gene Information | human ... SLC6A2(6530), SLC6A4(6532) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| Y0001453 | | Duloxetine Hydrochloride | European Pharmacopoeia (EP) Reference Standard | 1756.05元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 盐酸度洛西汀是一种双重血清素/去甲肾上腺素再摄取抑制剂(SNRI),在临床上被广泛用作抗抑郁药和抗焦虑药。 包装 Unit quantity: 120 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C18H19NOS · HCl | | 分子量 | 333.88 | | MDL编号 | MFCD06407958 | | PubChem化学物质编号 | 329831430 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3 | | InChI | 1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1 | | InChI key | BFFSMCNJSOPUAY-LMOVPXPDSA-N | | Gene Information | human ... SLC6A2(6530), SLC6A4(6532) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR1865 | Supelco | Duloxetine Hydrochloride | Pharmaceutical Secondary Standard; Certified Reference Material | 3586.98元/500 MG; | 展开 |
产品说明 一般描述 用于质量控制的制药二级标准品,为制药实验室和制造商提供了一种方便且经济的替代方案,可用于内部工作标准品的制备 生化/生理作用 盐酸度洛西汀是一种双重血清素/去甲肾上腺素再摄取抑制剂(SNRI),在临床上被广泛用作抗抑郁药和抗焦虑药。 分析说明 这些二级标准品可追溯至USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据ISO 17034和ISO/IEC 17025进行生产和认证。所有关于该 CRM 的信息都可以在分析证书上找到。 附注 要查看该材料的分析证书示例,请在下面的文档栏中输入LRAC1689。这只是一个示例证书,可能不是您收到的批次。 基本信息 | 经验(实验)分子式 | C18H19NOS · HCl | | 分子量 | 333.88 | | MDL编号 | MFCD06407958 | | NACRES | NA.24 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | 形式 | powder | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | application(s) | pharmaceutical | | 药典可追溯性 | traceable to PhEur Y0001453 traceable to USP 1229817 | | 储存温度 | 2-30℃ | | SMILES string | Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3 | | InChI | 1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1 | | InChI key | BFFSMCNJSOPUAY-LMOVPXPDSA-N | | Gene Information | human ... SLC6A2(6530), SLC6A4(6532) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1229817 | USP | Duloxetine Hydrochloride | United States Pharmacopeia (USP) Reference Standard | 8438.42元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 盐酸度洛西汀是一种双重血清素/去甲肾上腺素再摄取抑制剂(SNRI),在临床上被广泛用作抗抑郁药和抗焦虑药。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here. Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C18H19NOS · HCl | | 分子量 | 333.88 | | MDL编号 | MFCD06407958 | | PubChem化学物质编号 | 329749692 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | Cl.CNCC[C@H](Oc1cccc2ccccc12)c3cccs3 | | InChI | 1S/C18H19NOS.ClH/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16;/h2-10,13,17,19H,11-12H2,1H3;1H/t17-;/m0./s1 | | InChI key | BFFSMCNJSOPUAY-LMOVPXPDSA-N | | Gene Information | human ... SLC6A2(6530), SLC6A4(6532) |
安全信息 | 象形图 |  | | 警示用语: | Warning | | 危险声明 | H302 | | 预防措施声明 | P301 + P312 + P330 | | 危险分类 | Acute Tox. 4 Oral | | 储存分类代码 | 6.1D - Non-combustible, acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 079403 | Fluorochem | (S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride | 95% | 528元/250mg; 1034元/1g; 3058元/5g; 5082元/10g; | 展开 |
基本信息 | CAS Number | 136434-34-9 | | MDL Number | MFCD06407958 |
安全信息 | 图形或危害标志 |   | | 危险性说明 | H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation. H361fd: Reproductive toxicity
| | 防范说明 | P201: Obtain special instructions before use. P202: Do not handle until all safety precautions have been read and understood. P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|